- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06253052
Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients (HYDRATE)
May 20, 2025 updated by: Wuerzburg University Hospital
A Pilot Study to Test Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients
The purpose of this study is to show if - compared to standard practice - allowing adults undergoing surgical procedures under anaesthesia care to drink clear fluids up to a volume of 200 ml between 2 h prior to the operation and the call to operation room (approximately 30 min prior to anaesthesia induction) will decrease patient thirst and increase patient satisfaction.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
174
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Würzburg, Bavaria, Germany, 97080
- Wuerzburg University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult patients (≥ 18 years)
- American Society of Anesthesiologists (ASA) physical status classification I-III
- Undergoing surgical procedure under anaesthesia care: general anaesthesia, regional anaesthesia, combined anaesthesia or monitored anaesthesia care.
The proportion of Patients undergoing general or combined anaesthesia is aimed to exceed 75%
Exclusion Criteria:
Absolute indication for rapid sequence induction including but not limited to:
- Bowel obstruction including ileus
- Stricture and oesophageal disorders including achalasia
- Recent polytrauma or trauma of the upper gastrointestinal tract
- Acute abdomen/peritonitis including active gastrointestinal bleeding
Relative indication for (modified) rapid sequence induction includes, but is not limited to:
- Symptomatic gastroesophageal reflux disease, independent of food intake and persistent under medical treatment (PPI)
- Hiatus hernia or upside down stomach
- Upper gastrointestinal tumour
- History of upper gastrointestinal surgery (oesophageal, gastric, duodenum, pancreatic)
- Medically confirmed gastroparesis
- Severe obesity, defined as body mass index ≥ 40 kg/m2
- Dysphagia
- Renal replacement therapy
- Fluid restriction therapy
- Pregnancy
- Expected need for postoperative mechanical ventilation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
Fasting instructions as given by anaesthesiologist according to national guidelines (6 h solid meal and thick liquids, 2 h clear fluids).
|
|
|
Active Comparator: Instructed guideline adherence
Patients should not involuntarily fast fluids for longer than 2 h.
|
OP-schedule is closely monitored and patients will be visited to support and encourage them in drinking clear fluids.
|
|
Experimental: Experimental intervention
Patients should not involuntarily fast fluids for longer than 30 min.
|
OP-schedule is closely monitored and patients will be visited to support and encourage them in drinking clear fluids.
Patients may drink up to 200 ml clear fluids between 2 h prior to the surgery and the call to operation room.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thirst
Time Frame: Prior to induction of anaesthesia
|
At any stage after your hospital admission have you had the following: Thirst (No/ Yes, moderate/ Yes, severe)
|
Prior to induction of anaesthesia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of protocol deviations per group
Time Frame: From enrollment until last Follow-up is concluded at up to 48 hours post surgery
|
Outcome assessment successfully blinded Real fluid fasting time is less than allocated fluid fasting time
|
From enrollment until last Follow-up is concluded at up to 48 hours post surgery
|
|
Fluid fasting time
Time Frame: Prior to induction of anesthesia
|
Actual fluid fasting time in hours
|
Prior to induction of anesthesia
|
|
RASS
Time Frame: 2 hours after end of surgery
|
Richmond Agitation Sedation Scale.
A scale from -5 to +4 is used.
Negative values indicate a sedated state.
Positive values indicate an agitated state.
|
2 hours after end of surgery
|
|
CAM-ICU
Time Frame: 2 hours after end of surgery
|
Confusion Assessment Method for the Intensive Care Unit.
|
2 hours after end of surgery
|
|
Headache
Time Frame: Prior to induction of anesthesia and 2 hours after end of surgery
|
At any stage after your hospital admission have you had the following: Headache (No/ Yes, moderate/ Yes, severe)
|
Prior to induction of anesthesia and 2 hours after end of surgery
|
|
Change of systolic blood pressure on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
|
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
|
5 minutes prior and 15 minutes after induction of anesthesia
|
|
Change of diastolic blood pressure on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
|
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
|
5 minutes prior and 15 minutes after induction of anesthesia
|
|
Change of mean arterial pressure on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
|
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
|
5 minutes prior and 15 minutes after induction of anesthesia
|
|
Vasopressor
Time Frame: Within 15 minutes after induction of anesthesia
|
Use of Vasopressors
|
Within 15 minutes after induction of anesthesia
|
|
Blood glucose level
Time Frame: At induction of anesthesia (Values assessed within 15 minutes prior and 15 minutes after induction of anesthesia will be accepted)
|
Blood glucose level
|
At induction of anesthesia (Values assessed within 15 minutes prior and 15 minutes after induction of anesthesia will be accepted)
|
|
Intravenous catheter placement
Time Frame: Between admission to the operation room and induction of anesthesia
|
Number of attempts for placing a (first) peripheral intravenous catheter (only applicable if a peripheral intravenous catheter needs to be placed)
|
Between admission to the operation room and induction of anesthesia
|
|
Postoperative nausea and vomiting
Time Frame: 2 hours after end of surgery
|
Postoperative nausea and vomiting is a composite endpoint of the following dimensions: Vomiting, retching, nausea, and/or use of rescue medication.
|
2 hours after end of surgery
|
|
Unplanned ICU/IMC
Time Frame: From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
|
Unplanned intensive/intermediate care unit stay due to respiratory complications
|
From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
|
|
Number of Participants with confirmed bronchopulmonary aspiration
Time Frame: From induction of anesthesia until last Follow-up is concluded at up to 48 hours post surgery
|
If relevant bronchopulmonary aspiration is suspected, it needs to be confirmed by bronchoscopy or radiology imaging up to 48 hours after anaesthesia procedure
|
From induction of anesthesia until last Follow-up is concluded at up to 48 hours post surgery
|
|
All cause mortality
Time Frame: From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
|
Death within observation period
|
From end of surgery until last Follow-up is concluded at up to 48 hours post surgery
|
|
Change of heart rate on induction of anesthesia
Time Frame: 5 minutes prior and 15 minutes after induction of anesthesia
|
The difference between the highest value before induction of anesthesia and the lowest value after induction of anesthesia will be reported.
|
5 minutes prior and 15 minutes after induction of anesthesia
|
|
Patient satisfaction
Time Frame: 2 hours after end of surgery
|
Patient satisfaction, operationalized using the Bauer Satisfaction Questionnaire, includes 10 ordinal items with 3 levels (where higher values indicate unfavourable outcomes), 5 items on a Likert scale with 4 levels (where lower values indicate unfavourable outcomes), and one binary item.
|
2 hours after end of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Patrick Meybohm, Prof. Dr., University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany
- Principal Investigator: Tobias E Haas, Dr., University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 24, 2024
Primary Completion (Actual)
November 4, 2024
Study Completion (Actual)
November 4, 2024
Study Registration Dates
First Submitted
January 5, 2024
First Submitted That Met QC Criteria
February 9, 2024
First Posted (Actual)
February 12, 2024
Study Record Updates
Last Update Posted (Actual)
May 25, 2025
Last Update Submitted That Met QC Criteria
May 20, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HYDRATE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Aligarh Muslim UniversityCompletedAnesthesia | Anesthesia Intubation Complication | Anesthesia; Adverse EffectIndia
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Universitas Sebelas MaretIndonesia Endowment Fund for EducationNot yet recruitingAnesthesia | Anesthesia; Reaction
-
University Health Network, TorontoActive, not recruiting
-
University of PecsCompleted
-
Hormozgan University of Medical SciencesUnknownAnesthesia | Anesthesia; FunctionalIran, Islamic Republic of
-
Children's Hospital Los AngelesNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingAnesthesia | Anesthesia; ReactionUnited States
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruiting
Clinical Trials on Additional pre-OP-visit
-
International Medical UniversityKotra Pharma (M) Sdn BhdCompletedCancer of Breast | Cancer ColonMalaysia
-
Mayo ClinicTerminatedObesityUnited States
-
Dr. Muhammad NaeemCompletedCholelithiasis | Epigastric Hernia | Duodenal PerforationPakistan
-
University of California, DavisActive, not recruitingLung CancerUnited States
-
Eric ParentWomen and Children's Health Research Institute (WCHRI)Enrolling by invitation
-
Inje UniversityCompleted
-
Özge İşeriCompletedAnxiety | Recovery QualityTurkey (Türkiye)
-
University of California, DavisCompletedDiabetes Mellitus, Type 2 | Multiple Chronic ConditionsUnited States
-
Cedars-Sinai Medical CenterSuspendedHyperprolactinemia | Spontaneous Intracranial HypotensionUnited States
-
Brigham and Women's HospitalNational Institute on Aging (NIA); University of Southern CaliforniaNot yet recruitingDeprescribing | Statin Prescribing